INS and Insulin resistance: Similarly, saxagliptin treatment was not associated with changes in early insulin response (as measured using the 30-min insulinogenic index), insulin sensitivity (based on OGIS and Matsuda indices) or insulin resistance (HOMA-2IR assessment) vs. uptitrated glyburide.